Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Suanfarma, at the Core of a Better Life.
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
TAPI offers customized CDMO Solutions for API development and manufacturing services.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Tivozanib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tivozanib, including repackagers and relabelers. The FDA regulates Tivozanib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tivozanib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tivozanib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tivozanib supplier is an individual or a company that provides Tivozanib active pharmaceutical ingredient (API) or Tivozanib finished formulations upon request. The Tivozanib suppliers may include Tivozanib API manufacturers, exporters, distributors and traders.
click here to find a list of Tivozanib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tivozanib DMF (Drug Master File) is a document detailing the whole manufacturing process of Tivozanib active pharmaceutical ingredient (API) in detail. Different forms of Tivozanib DMFs exist exist since differing nations have different regulations, such as Tivozanib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tivozanib DMF submitted to regulatory agencies in the US is known as a USDMF. Tivozanib USDMF includes data on Tivozanib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tivozanib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tivozanib suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tivozanib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tivozanib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tivozanib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tivozanib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tivozanib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tivozanib suppliers with NDC on PharmaCompass.
Tivozanib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tivozanib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tivozanib GMP manufacturer or Tivozanib GMP API supplier for your needs.
A Tivozanib CoA (Certificate of Analysis) is a formal document that attests to Tivozanib's compliance with Tivozanib specifications and serves as a tool for batch-level quality control.
Tivozanib CoA mostly includes findings from lab analyses of a specific batch. For each Tivozanib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tivozanib may be tested according to a variety of international standards, such as European Pharmacopoeia (Tivozanib EP), Tivozanib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tivozanib USP).
LOOKING FOR A SUPPLIER?
